In Vitro Phase I Metabolism of CRV431, a Novel Oral Drug Candidate for Chronic Hepatitis B
The cytochrome P450-mediated Phase I in vitro metabolism of CRV431 was studied using selective chemical inhibition and recombinant human enzymes. Additionally, the metabolic profile of CRV431 in human, rat, and monkey liver microsomes was investigated. Liver microsomes were incubated for 0–80 min wi...
Main Authors: | Daniel J. Trepanier, Daren R. Ure, Robert T. Foster |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-11-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/9/4/51 |
Similar Items
-
Perpendicular Magnetic Anisotropy in FePt Patterned Media Employing a CrV Seed Layer
by: Chun Dong, et al.
Published: (2011-01-01) -
Effect of Quenching Conditions on the Microstructure and Mechanical Properties of 51CrV4 Spring Steel
by: Lin Zhang, et al.
Published: (2018-12-01) -
Investigation into Effects of Different Tempering Temperatures on Mechanical Properties of 51CrV4 Steel
by: Hülya DURMUŞ, et al.
Published: (2020-09-01) -
Cyclophilin Inhibitors: An Emerging Class of Therapeutics for the Treatment of Chronic Hepatitis C Infection
by: Philippe Gallay, et al.
Published: (2012-10-01) -
Development, Characterization, and Pharmacokinetic Evaluation of a CRV431 Loaded Self-Microemulsifying Drug Delivery System
by: Daniel J Trepanier, et al.
Published: (2018-11-01)